Cargando…

Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma

Although the “seed and soil” hypothesis was proposed by Stephen Paget at the end of the 19th century, where he postulated that tumor cells (seeds) need a propitious medium (soil) to be able to establish metastases, only recently the tumor microenvironment started to be more studied in the field of O...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernando, Rodrigo Carlini, de Carvalho, Fabrício, Leme, Adriana Franco Paes, Colleoni, Gisele Wally Braga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021918/
https://www.ncbi.nlm.nih.gov/pubmed/33833982
http://dx.doi.org/10.3389/fonc.2021.563384
_version_ 1783674835981828096
author Fernando, Rodrigo Carlini
de Carvalho, Fabrício
Leme, Adriana Franco Paes
Colleoni, Gisele Wally Braga
author_facet Fernando, Rodrigo Carlini
de Carvalho, Fabrício
Leme, Adriana Franco Paes
Colleoni, Gisele Wally Braga
author_sort Fernando, Rodrigo Carlini
collection PubMed
description Although the “seed and soil” hypothesis was proposed by Stephen Paget at the end of the 19th century, where he postulated that tumor cells (seeds) need a propitious medium (soil) to be able to establish metastases, only recently the tumor microenvironment started to be more studied in the field of Oncology. Multiple myeloma (MM), a malignancy of plasma cells, can be considered one of the types of cancers where there is more evidence in the literature of the central role that the bone marrow (BM) microenvironment plays, contributing to proliferation, survival, migration, and drug resistance of tumor cells. Despite all advances in the therapeutic arsenal for MM treatment in the last years, the disease remains incurable. Thus, studies aiming a better understanding of the pathophysiology of the disease, as well as searching for new therapeutic targets are necessary and welcome. Therefore, the present study aimed to evaluate the protein expression profiling of mononuclear cells derived from BM of MM patients in comparison with these same cell types derived from healthy individuals, in order to fill this gap in MM treatment. Proteomic analysis was performed using the mass spectrometry technique and further analyses were done using bioinformatics tools, to identify dysregulated biological pathways and/or processes in the BM microenvironment of patients with MM as a result of the disease. Among the pathways identified in this study, we can highlight an upregulation of proteins related to protein biosynthesis, especially chaperone proteins, in patients with MM. Additionally, we also found an upregulation of several proteins involved in energy metabolism, which is one of the cancer hallmarks. Finally, with regard to the downregulated proteins, we can highlight mainly those involved in different pathways of the immune response, corroborating the data that has demonstrated that the immune system of MM is impaired and, therefore, the immunotherapies that have been studied recently for the treatment of the disease are extremely necessary in the search for a control and a cure for these patients who live with the disease.
format Online
Article
Text
id pubmed-8021918
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80219182021-04-07 Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma Fernando, Rodrigo Carlini de Carvalho, Fabrício Leme, Adriana Franco Paes Colleoni, Gisele Wally Braga Front Oncol Oncology Although the “seed and soil” hypothesis was proposed by Stephen Paget at the end of the 19th century, where he postulated that tumor cells (seeds) need a propitious medium (soil) to be able to establish metastases, only recently the tumor microenvironment started to be more studied in the field of Oncology. Multiple myeloma (MM), a malignancy of plasma cells, can be considered one of the types of cancers where there is more evidence in the literature of the central role that the bone marrow (BM) microenvironment plays, contributing to proliferation, survival, migration, and drug resistance of tumor cells. Despite all advances in the therapeutic arsenal for MM treatment in the last years, the disease remains incurable. Thus, studies aiming a better understanding of the pathophysiology of the disease, as well as searching for new therapeutic targets are necessary and welcome. Therefore, the present study aimed to evaluate the protein expression profiling of mononuclear cells derived from BM of MM patients in comparison with these same cell types derived from healthy individuals, in order to fill this gap in MM treatment. Proteomic analysis was performed using the mass spectrometry technique and further analyses were done using bioinformatics tools, to identify dysregulated biological pathways and/or processes in the BM microenvironment of patients with MM as a result of the disease. Among the pathways identified in this study, we can highlight an upregulation of proteins related to protein biosynthesis, especially chaperone proteins, in patients with MM. Additionally, we also found an upregulation of several proteins involved in energy metabolism, which is one of the cancer hallmarks. Finally, with regard to the downregulated proteins, we can highlight mainly those involved in different pathways of the immune response, corroborating the data that has demonstrated that the immune system of MM is impaired and, therefore, the immunotherapies that have been studied recently for the treatment of the disease are extremely necessary in the search for a control and a cure for these patients who live with the disease. Frontiers Media S.A. 2021-03-23 /pmc/articles/PMC8021918/ /pubmed/33833982 http://dx.doi.org/10.3389/fonc.2021.563384 Text en Copyright © 2021 Fernando, de Carvalho, Leme and Colleoni http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Fernando, Rodrigo Carlini
de Carvalho, Fabrício
Leme, Adriana Franco Paes
Colleoni, Gisele Wally Braga
Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma
title Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma
title_full Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma
title_fullStr Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma
title_full_unstemmed Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma
title_short Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma
title_sort tumor microenvironment proteomics: lessons from multiple myeloma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021918/
https://www.ncbi.nlm.nih.gov/pubmed/33833982
http://dx.doi.org/10.3389/fonc.2021.563384
work_keys_str_mv AT fernandorodrigocarlini tumormicroenvironmentproteomicslessonsfrommultiplemyeloma
AT decarvalhofabricio tumormicroenvironmentproteomicslessonsfrommultiplemyeloma
AT lemeadrianafrancopaes tumormicroenvironmentproteomicslessonsfrommultiplemyeloma
AT colleonigiselewallybraga tumormicroenvironmentproteomicslessonsfrommultiplemyeloma